The Comparison of Candida spp. Colonization on Psoriasis Vulgaris Patient and Control
Downloads
Background: Psoriasis is an inflammatory, chronic, and recurring skin disease that affects patient's quality of life. Environment, drugs, and infections in the form of antigen and toxin such as Candida spp. are assumed responsible for triggering and exacerbating psoriasis. Purpose: To compare the prevalence of skin colonization of Candida spp. on psoriasis vulgaris patient and control. Methods: This study was observational analytic research involving 33 psoriasis vulgaris patients and 33 healthy individuals. They were matched up based on sex, age, and lesion location. Swab of skin lesions on the Koebner area of both groups was cultured on CHROMagar media. Candida spp. was later identified and the colonization was calculated. Result: Candida spp. was found on 51.5% of lesions in psoriasis vulgaris patients and 21.2% in the control group with a significant difference of p < 0.05. The average colony number of Candida spp. in psoriasis vulgaris group was lower than the control group with no significant difference of p > 0.05. The predominant Candida spp. in the psoriasis vulgaris and control groups was Candida krusei, which were 35.5% and 85.6%, respectively. No significant difference between sex, age, period of complaints, age onset, degree of severity (Psoriasis Area and Severity Index), and therapy history, with positive culture of Candida spp. Conclusion: There was no difference in the number of Candida spp. colonization in the psoriasis vulgaris group and the control group. However, the culture positivity of Candida spp. in the psoriasis vulgaris patients was higher than in the control group.
Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci 2019; 20(1475):1–28.
Gudjonsson JE, Elder JT. Psoriasis. In: Kang S, Amagai M, Bruckner A, Enk AH, Margolis DJ, McMichael AJ, et al., editors. Fitzpatrick's Dermatology. New York: McGraw-Hill Education; 2019.p.457–97.
Meglio P Di, Villanova F, Nestle FO. Psoriasis. Cold Spring Harb Perspect Med 2014; 4:1–31.
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci 2019; 20(18):1–14.
Lewis DJ, Chan WH, Hinojosa T, Hsu S, Feldman SR. Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: A review. Clin Dermatol 2019; 37(2):160–6.
Nazik H, Nazik S, Gul FC. Body image, self-esteem, and quality of life in patients with psoriasis. Indian Dermatol Online J 2017; 8(5):343–6.
Devore-Carter D, Kar S, Vellucci V, Bhattacherjee V, Domanski P, Hostetter MK. Superantigen-like effects of a Candida albicans polypeptide. J Infect Dis 2008;197(7): 981–9.
Sepahi S, Riahi-Zanjani B, Ghorani-Azam A. The role of Candida albicans in the pathogenesis of psoriasis vulgaris: a systematic literature review. Rev Clin Med 2016; 3(3):122–7.
Sarvtin MT, Shokohi T, Hajheydari Z, Yazdani J, Hedayati MT. Evaluation of candidal colonization and specific humoral responses against Candida albicans in patients with psoriasis. Int J Dermatol 2014; 53(12):e555–60.
Pezeshkpoor F, Yazdanpanah MJ, Family SZ, Sepahi S. Prevalence of Candida in saliva and skin lesions of psoriasis vulgaris patients. J Mycol Res 2015; 2(1):9–14.
Kühbacher A, Burger-kentischer A, Rupp S. Interaction of Candida species with the skin. Microorganisms 2017; 5(2):1–12.
van der Meer JWM, van de Veerdonk FL, Joosten LAB, Kullberg BJ, Netea MG. Severe Candida spp. infections: New insights into natural immunity. Int J Antimicrob Agents 2010; 36:S58–62.
Ogawa E, Okuyama R, Seki T, Kobayashi A, Oiso N, Muto M, et al. Epidemiological survey of patients with psoriasis in Matsumoto city, Nagano Prefecture, Japan. J Dermatol 2018; 45(3):314–7.
Chiu HY, Wang TS, Chen PH, Hsu SH, Tsai YC, Tsai TF. Psoriasis in Taiwan: From epidemiology to new treatments. Dermatologica Sin 2018; 36(3):115–23.
Chularojanamontri L, Wongpraparut C, Tuchinda P, Winayanuwattikun W, Boonyasiri A, Kulthanan K, et al. Oral Candida colonization in Thai patients with psoriasis. J Med Assoc Thail 2016; 99(1):84–7.
Rafat Z, Hashemi SJ, Ahamdikia K, Daie Ghazvini R, Bazvandi F. Study of skin and nail Candida species as a normal flora based on age groups in healthy persons in Tehran-Iran. J Mycol Med 2017; 27(4):501–5.
Somerville DA. The normal flora of the skin in different age groups. Br J Dermatol 1969; 81(4):248–58.
Lee Y, Je Y, Lee S, Li ZJ, Choi D, Kwon Y, et al. Changes in transepidermal water loss and skin hydration according to expression of aquaporin-3 in psoriasis. Ann Dermatol 2012; 24(2):168–74.
Bedair AA, Darwazeh AMG, Al-Aboosi MM. Oral Candida colonization and candidiasis in patients with psoriasis. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114(5):610–5.
Waldman A, Gilhar A, Duek L, Berdicevsky I. Incidence of Candida in psoriasis a study on the fungal flora of psoriatic patients. Mycoses 2001; 44:77–81.
Pietrzak A, Grywalska E, Socha M, RoliÅ„ski J, Franciszkiewicz-Pietrzak K, Rudnicka L, et al. Prevalence and possible role of Candida species in patients with psoriasis: A systematic review and meta-analysis. Hindawi Mediat Inflamm 2018; (Article ID 9602362):1–7.
Henseler T. Mucocutaneous candidiasis in patients with skin diseases. Mycoses 1995; 38(Suppl 1):7–13.
Henseler T, Tausch I. Mycoses in patients with psoriasis or atopic dermatitis. Mycoses 1997; 40(Suppl 1):22–8.
OvÄina-Kurtović N, Kasumagić-Halilović E, Helppikangans H, Begić J. Prevalence of Candida species in patients with psoriasis. Acta Dermatovenerologica Croat 2016; 24(3):209–13.
Papon N, Courdavault V, Clastre M, Bennett RJ. Emerging and emerged pathogenic Candida species: Beyond the Candida albicans paradigm. PLoS Pathog 2013; 9(9):e1003550.
Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJS. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013; 62(1):10–24.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
